MDXG FY 2012 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$677M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+248.6% YoY

Gross Profit

$22M80.8% margin

Operating Income

-$2M-7.4% margin

Net Income

-$8M-28.3% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$35M

Total Liabilities

$15M

Stockholders' Equity

$20M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$8M	+248.6%
Gross Profit	$22M	$5M	+374.7%
Operating Income	-$2M	-$10M	+79.6%
Net Income	-$8M	-$10M	+24.8%